Year of Award:
2018
Status:
Complete
Award Type:
R33
Project Number:
CA214310
RFA Number:
RFA-CA-17-013
Technology Track:
Biospecimen Science Technologies
PI/Project Leader:
INCE, TAN A.
Other PI or Project Leader:
N/A
Institution:
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
External Link:
https://projectreporter.nih.gov/project_info_description.cfm?aid=9443011
Many steps of cancer drug development involves the use of standard cancer cell lines (SCCL)which have been instrumental in the development of many targeted therapies; including Herceptin, Gleevac andTamoxifen among others. However, establishing new CCL th